Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-24

Clinical Trial Update: Dinoprostone Induction vs. Expectant Management After PROM at Term [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing dinoprostone induction to expectant management after prelabor rupture of membranes at term.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dinoprostone (dinoprostone)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Prelabor Rupture of Membranes | Phase 4 | Status: UNKNOWN